Sort   by:  
 Page size 
UnknownSingle-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy.
Not available
S-EPMC10916538 | biostudies-literature
ProteomicsEffect of SMARCA2/SMARCA4 inhibitor, FHD-286, on protein expression alterations in cultured cell line or patient-derived AML cells with MECOM rearrangement and expression of EVI1
Patient-derived AML191 (acute myeloid leukemia with inv3(q21;q26.2)), -7) cells were treated in duplicate with 100 nM of FHD-286 for 0, 8, 16, 24 and 48 hours to determine the global protein expression alterations that correlate with the cell cycle, growth inhibitory and lethal effects of treatment ...
ORGANISM(S): Homo sapiens (Human) 
2026-01-23 | PXD059059 | Pride
Mecom Brg1 Evi1 Fhd-286 Aml 
ProteomicsProject title: Effect of FHD-286 or BRG1/BRM degrader AU15330 on protein expressions in MLL1-rearranged AML cells
MOLM13 cells and patient-derived de novo AML cells with MLL1 rearrangement were treated with 100 nM of FHD-286 or 100 nM of AU15330, a dual BRG1/BRM protein degrader for 48 hours. The goal was to determine the global protein expression alterations that correlate with the cell cycle, growth inhibitor...
ORGANISM(S): Homo sapiens (Human) 
2025-04-28 | PXD055994 | Pride
Fhd-286 Au15330 Protac Chromatin 
UnknownClearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia.
Not available
S-EPMC6008108 | biostudies-literature
UnknownModeling the Reaction of Carboxylic Acids and Isonitriles in a Self-Assembled Capsule.
Not available
S-EPMC7522688 | biostudies-literature
UnknownInotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia.
Not available
S-EPMC9096877 | biostudies-literature
UnknownTaking aim at IDH in fitter patients with AML.
Not available
S-EPMC9999040 | biostudies-literature
UnknownTargeting CD47/SIRPα in Acute Myeloid Leukemia and Myelodysplastic Syndrome: Preclinical and Clinical Developments of Magrolimab.
Not available
S-EPMC9153253 | biostudies-literature
UnknownCharacteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD.
Not available
S-EPMC9131912 | biostudies-literature
UnknownPhase II study of pomalidomide in combination with prednisone in patients with myelofibrosis and significant anemia.
Not available
S-EPMC4157096 | biostudies-literature
Sort   by:  
 Page size